Board documents
11-12 June 2025

Board Meeting 46

The Forum, Global Health Campus Geneva, Switzerland

Minutes:

Resolutions:

R1 - Audited Financial Statements for 2024 and Report of the External Auditor
R2 - Proposal Review Committee replenishment
R3 - Proposal Review Committee leadership selection and performance assessment process

Documents:

Provisional Agenda
Report from the Executive Director
2023-2027 Strategy – Key Performance Indicator report (June 2025)
Audited financial statements for the year ended 31 December 2024
Proposal Review Committee replenishment
Proposal Review Committee Terms of Reference
02-05 December 2024

Board Meeting 45

Johannesburg, South Africa

Resolutions:

R1 - Implementation of the Functional Review
R2 - Area for Intervention "Climate & Health"
R3 - Amendment of PRC Terms of Reference
R4 - Approval of the 2025 Unitaid Budget

Documents:

Minutes from the 44th meeting of the Executive Board, 18-19 June 2024
Provisional Agenda
Report from the Executive Director
Area for Intervention: Support and accelerate the transition towards climate-smart health products
Proposal Review Committee. Terms of Reference
Proposed changes to the PRC composition and areas of expertise
18-19 June 2024

Board Meeting 44

Global Health Campus Geneva, Switzerland

Resolutions:

R11 - Extension of invitation to Japan to occupy the Temporary Executive Board Seat
R10 - Extension of appointment of the Members of the Policy and Strategy Committee and the Finance and Accountability Committee
R9 - Extension of appointment of the Chairs and Vice-Chairs of the Policy and Strategy Committee and the Finance and Accountability Committee
R8 - Amendments to the Code of Ethical Conduct for Unitaid Board Constituencies and Governance Officials
R7 - Audited Financial Statements for 2023 and Report of the External Auditor
R6 - Area for Intervention “Regional Manufacturing for Equitable Access” (RMEA}
R5 - Area for Intervention “Improving people-centred care through integrated diagnostic tools and delivery approaches”
R4 - Area for Intervention “Improving access to innovations in sustainable oxygen production, distribution and supply”
R3 - Area for Intervention “Improving risk detection and management of pre-eclampsia”
R2 - Area for Intervention “Improving access to care for moderate and severe anaemia in vulnerable groups in LMICs”
R1 - Functional Review

Documents:

Provisional Agenda
Minutes from the 43rd meeting of the Executive Board
Report from the Executive Director
2023-2027 Strategy – Key Performance Indicator report (June 2024)
Area for Intervention: Improving access to care for moderate and severe anaemia in vulnerable groups in LMICs
Area for Intervention: Improving risk detection and management of pre-eclampsia
Area for Intervention: Improving access to innovations in sustainable oxygen production, distribution, and supply
Area for Intervention: Improving people-centered care through integrated diagnostic tools and delivery approaches
Area for Intervention: Regional Manufacturing for Equitable Access (RMEA)
Audited financial statements 2023
Report of the external auditor 2023
Code of Ethical Conduct for Unitaid Board Constituencies and Governance Officials
21-22 November 2023

Board Meeting 43

Brasilia, Brazil

Resolutions:

R9 - Policy for the acceptance of Specified Contributions
R8 - Revisions to 2022 Operating Budget
R7 - Revisions to 2023 Operating Budget
R6 - Approval of the 2024 Unitaid Budget
R5 - Climate and Health Strategy
R4 - Area for Intervention: Enabling access to monoclonal antibodies to treat and prevent infectious diseases in LMICs
R3 - Extension of term of the Unitaid Board Vice-Chair
R2 - Extension of term of the Unitaid Board Chair
R1 - Approval of revisions to the KPI framework

Documents:

Provisional Agenda
Minutes from the 42nd meeting of the Executive Board
Annex 1: Exchange of letters between Board Chair and Executive Director
Annex 2: Executive Director Report on Objectives
Report from the Executive Director
Annex A: Key Performance Indicator report, Mission Strategic Objective KPIs
Annex B: Key Performance Indicator report Organizational KPIs
Policy for acceptance of Specified Contributions
Area for Intervention: Enable access to monoclonal antibodies to treat and prevent infectious diseases in LMICs
Annex: Climate and Health Strategy Performance Framework
Climate and Health Strategy
14-15 June 2023

Board Meeting 42

Global Health Campus Geneva, Switzerland

Resolutions:

R7 - Scheduling of the 43rd Executive Board meeting
R6 - Unitaid Commitment Policy
R5 - Audited Financial Statements for 2022 and Report of the External Auditor
R4 - Renewal of the appointments of the Chair and appointment of the Vice Chair of the Proposal Review Committee
R3 - Unitaid Functional Review
R2 - Area for Intervention: Accelerate access to tools to drive Elimination of Mother-to-Child Transmission (EMTCT) of HIV, syphilis, and hepatitis B, including Chagas in endemic areas
R1 - Area for Intervention: Accelerate and promote responsible introduction of new DR-TB drugs and regimens

Documents:

Provisional Agenda
Minutes of the 41th Session of the Executive Board
Report from the Executive Director
Area for Intervention: Accelerate and promote responsible introduction of new DR-TB drugs and regimens
Area for Intervention: Accelerate access to tools to drive Elimination of Mother-to-Child Transmission (EMTCT) of HIV, syphilis, and hepatitis B, including Chagas in endemic areas
Audited Financial Statements 2022
Commitment Policy
05-06 December 2022

Board Meeting 41

Global Health Campus Geneva, Switzerland

Resolutions:

R3 - Extension of the invitation to Japan to occupy the temporary Executive Board seat
R2 - Approval of the 2023 Unitaid Budget
R1 - Area for Intervention: “Mitigating antimalarial drug resistance”

Documents:

Provisional Agenda
Report from the Executive Director
2023: Proposed Operating Expenses Budget
Area for Intervention: Mitigating antimalarial drug resistance in Africa (Malaria Programmatic Priority: Improve access to quality case management)
15-16 June 2022

Board Meeting 40

Global Health Campus Geneva, Switzerland

Minutes:

Resolutions:

R7 - Audited Financial Statements for 2021 and Opinion of the External Auditor
R6 - Replenishment of Unitaid’s Proposal Review Committee
R5 - Appointment of the Members of the Policy and Strategy Committee and the Finance and Accountability Committee
R4 - Appointment of the Chairs and Vice-Chairs of the Policy and Strategy Committee and the Finance and Accountability Committee
R3 - Election of Executive Board Vice-Chair
R2 - Approval of key performance indicators for the 2023 – 2027 strategic period
R1 - Adoption of Unitaid’s 2023-2027 Strategy

Documents:

Provisional Agenda
Report from the Executive Director
Unitaid Strategy 2023-2027
Annex A: Mission Strategic Objective KPIs
Annex B: Organizational KPIs
Annex C: Target Access Profile
2023-2027 Strategy – Key Performance Indicators
Audited financial statements for the year ended 31 December 2021
Report of the External Auditor
Strategic and Operational Key Performance Indicators 2021
Annex 1: Strategic Key Performance Indicators (KPIs)
Annex 2: OperationaKey Performance Indicators (KPIs)
15-16 December 2021

Board Meeting 39

Virtual meeting

Minutes:

Resolutions:

R1 - Approval of the 2022 Unitaid Budget
R2 - Extension of appointment of the Chairs, Vice- Chairs and Members of the Policy and Strategy Committee and the Finance and Accountability Committee
R3 - Governance Working Group Extension of mandate and appointment of Chair and members
R4 - Review of Board Composition and Evolution
R5 - Election of Unitaid Executive Board Chair

Documents:

Provisional Agenda
Report from the Executive Director
1 2 3 6

2025

July

R27-2025-e

Costed Extension for the Project “Country- and Community-led Scaleup of Accessible, Integrated and Family-centered Elimination of Vertical Transmission (EVT) Plus Services for a Healthy Start: SAFEStart+”

R26-2025-e

Cost Extension for the Project “Improved Access to AHD Care and Treatment 4 HIV” (IMPAACT4HIV)

R25-2025-e

Catalysing the Adoption of a Novel Vector Control Toolbox (CANVeCT)

R24-2025-e

Medicines Supply Resilience Africa (MedSuRe)

R23-2025-e

Manufacturing to Accelerate Diagnostic Excellence (MADE) in Africa

R22-2025-e

Funding support for MPP’s role in the MedSure Project

June

R21-2025-e

Launch of the new Board Chair election process

R20-2025-e

“Enabling access to new multi-disease diagnostic tools” Project

1 2 3 29

Code of ethical conduct for Unitaid board constituencies and governance officials

Unitaid constitution

Board operating procedures